Global Medical Director, Multiple Myeloma

GlaxoSmithKline•Philadelphia, PA

3d•Remote

About The Position

The Global Medical Director in Multiple Myeloma is a unique opportunity for an experienced, innovative, and proactive medical professional to facilitate the understanding of the value of our medicines, the science behind them and the public impact they can offer. This is accomplished by developing and implementing the global medical scientific strategic plan to generate insights, shape optimal care through scientific dialogue and education and delivering impact by generating and communicating the evidence and delivering solutions to close the gaps. The Global Medical Director for Multiple Myeloma will work in a thriving team of medical business leaders where people will be inspired to drive towards achieving our goals of getting Ahead of Disease Together and positively impacting patient and population health outcomes globally to help close gaps in medical care. Working independently, the Medical Director is capable of fully leading designated aspects of the Medical Affairs strategic planning process and its implementation on behalf of the Executive Director and Global Medical Affairs Leader (GMAL) and in collaboration with their peers and other functions in the medical affairs team. The scope of the role therefore mirrors parts of the scope of the GMAL role, to whom she/he is accountable. This may include the following activities: · Plays an integral role in building/optimizing the Global Medical Affairs Plan (MAP) and Integrated Evidence Plan (IEP) for the relevant asset/indication(s). · Drives delivery of designated above-country elements of the MAP, e.g., Advisory Boards, Symposia, Educational Events. · P artners with commercial colleagues to optimize brand strategy, campaigns and launches in the Franchise Local Operating Companies (LOCs). · Leading and overseeing partnerships from a GMA perspective for the relevant asset/indication(s). · Drives the development and/or approval of promotional, educational, training and other materials and responses. · Drives the congress planning and coordination from a brand perspective, including pre- and post-congress deliverables. · Drives the scientific training coordination and execution from a brand perspective, including material development and/or approval. · Delivers the evidence needs for that asset on behalf of the GMAL: o Drives the efficient working of the Integrated Evidence Team; ensuring insights from Franchise LOCs are integrated appropriately to inform the IEP. o Reviews local GSK-sponsored and Investigator Sponsored Study (ISS) proposals from Franchise LOCs to assess their scientific merit and strategic need, liaising with R D experts. o Accountable for the development of assigned Franchise study protocols. o Accountable for developing the strategy and critically assessing the post hoc analysis plan, outputs and strategy. · D rives excellence in Scientific Engagement (SE) with key stakeholders (HCPs, Patients, Payors and Regulators) to gain a deep understanding of customer needs. · D eputizes regularly for the GMAL as required.

Requirements

5+ years of Medical Affairs including roles in LOCs and supporting pre/peri launch phases of assets in the oncology / haematology space.
Robust experience leading post hoc analysis planning and execution.
Competency with promotional codes/regulations; previous involvement in review and approval processes.
Demonstrated experience leading external engagement strategy at the local or global level.
Ability to work across time zones and to travel internationally (25%- 50%).
Must possess strong interpersonal, verbal, and written communication skills in English

Nice To Haves

Previous clinical or scientific experience in Multiple Myeloma and hematology.
Robust understanding of internal and external codes of practice and regulations (certification where applicable).
Experience in medical support for briefing documents for regulatory interactions and payor dossiers.
Demonstrated experience with developing global or local medical strategies and asset launches, especially within a priority market.
Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimize medical implementation of innovation.

Responsibilities

Support the Global Medical Portfolio and Asset Strategy Leads in the development and timely execution of practice changing Global Medical Affairs Plans (MAP) and Integrated Evidence plans (IEP) in partnership with key stakeholders through the GMAT and IET
Thinks globally, while deeply understands priority LOC (Local Operating Company) needs and success measures. This is accomplished through extensive partnership and collaboration with LOC teams to understand landscape, market value drivers, unmet medical needs and timelines for deliverables required for their success.
Partners across the internal ecosystem and with external partners to deliver Medical Plans that prioritize external impact above all else on time and on budget
Leveraging insights and learnings, inputs into the design of clinical trials and development plans to optimize the positive impact for patients. Further, drives post hoc analysis strategy and plan to support evidence generation and publications aligned to global medical strategy in the post launch setting.
Drives excellence in scientific engagement by developing a strong collaborative network of global external experts (HCPs, patients, payors and regulators) to be engaged in advice seeking activities and appropriate initiatives to advance clinical care and patient outcomes in partnership with the LOC Medical teams where those experts reside
Ensures colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their training by partnering on the creation and delivery of high-quality scientific materials for both internal and external use
Partner with Global Product Strategy, Market Access, and core country teams to support/advise on core claims and material review
Ensure appropriate medical governance oversight including management of product-related issues with potential impact on patient safety and of risk assessment and mitigation plan associated with deliverables/strategies
Development of deep subject matter expertise on the product and therapy area as well as the ability to drive proactive strategic planning
Drive a culture and delivery mindset of future ready innovation which supports faster and specific solutions for patients
Engages across the ecosystem, including R D, Evidence Generation, Global Product Strategy, and country teams to support and lead identification and prioritization of evidence generation needs to close gaps and support the optimization of clinical care all aligned via the IEP
Review GSK-sponsored and investigator-sponsored study (ISS) proposals to assess their strategic alignment and scientific merit, in liaison with R D, safety, biostats and other expertsLeads the creation and implementation of an integrated external medical communications plan which is optimized to deliver external impact and considers all channels (including publications and congresses) and key market needs
Develop and communicate the strategic publications plan in collaboration with the Publications Lead and other stakeholders